Clinical Study
The Value of Surgery for Retroperitoneal Sarcoma
Table 3
Univariate analysis of prognostic factors for overall survival in 41 patients with primary retroperitoneal sarcoma.
| Variable | | 5-year survival (%) | -value |
| Sex | | | 0.89 | Female | 18 | 55 | | Male | 23 | 48 | | Age | | | 0.14 | 55 years | 16 | 76 | | 55 years | 25 | 33 | | Duration of symptoms | | | 0.53 | 6 month | 25 | 52 | | 6 months | 11 | 0 | | Unknown | 5 | 50 | | Histological subtype | | | 0.94 | Liposarcoma | 22 | 77 | | Leiomyosarcoma | 7 | 60 | | MFH | 4 | 33 | | Other | 8 | 0 | | Tumor size | | | 0.26 | 5 cm | 2 | 100 | | 5–10 cm | 4 | 100 | | 10–20 cm | 18 | 21 | | 20 cm | 17 | 60 | | Tumor grade | | | 0.05 | Low | 17 | 100 | | High | 24 | 27 | | Resection | | | 0.39 | R0/R1 | 38 | 42 | | R2 | 3 | 50 | | Resection high-grade tumor only | | | 0.03 | R0/R1 | 22 | 74 | | R2 | 2 | 44 | | Radiation therapy | | | 0.40 | Yes | 19 | 53 | | No | 22 | 63 | | Chemotherapy | | | 0.57 | Neo-adjuvant | 5 | 30 | | Adjuvant | 2 | — | | Both | 1 | — | | None | 33 | 43 | |
|
|
Multivariate analysis significant for grade ().
|